3/18/14 16:01 | 3/14/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 239 | 44 | -40 | -17 | -6 | -18 | 8 | 5 | -5 | -19 | -24 | -39 | -43 | -51 |
3/18/14 16:01 | 3/14/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -103 | 51.34 | 33 | -2 | -100 | 0 | D | 239 | 44 | -40 | -17 | -6 | -18 | 8 | 5 | -5 | -19 | -24 | -39 | -43 | -51 |
2/18/14 16:05 | 2/14/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 270 | 118 | -28 | -23 | -14 | 11 | 8 | -5 | -3 | 7 | -14 | -51 | -54 | -61 |
2/18/14 16:05 | 2/14/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -127 | 63.49 | 33 | -2 | -100 | 0 | D | 270 | 118 | -28 | -23 | -14 | 11 | 8 | -5 | -3 | 7 | -14 | -51 | -54 | -61 |
1/21/14 16:01 | 1/16/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 315 | 133 | -21 | -27 | -8 | -10 | -15 | 3 | -1 | -9 | 0 | -29 | -56 | -59 |
1/21/14 16:01 | 1/16/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -117 | 58.63 | 33 | -2 | -100 | 0 | D | 315 | 133 | -21 | -27 | -8 | -10 | -15 | 3 | -1 | -9 | 0 | -29 | -56 | -59 |
1/6/14 16:01 | 1/2/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 13 | 13.01 | 33 | 1 | | 0 | D | 339 | 171 | 3 | -23 | 14 | 13 | 6 | 2 | 0 | -4 | -14 | -36 | -51 | -62 |
1/6/14 16:01 | 1/2/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -71 | 70.93 | 33 | -1 | -100 | 0 | D | 339 | 171 | 3 | -23 | 14 | 13 | 6 | 2 | 0 | -4 | -14 | -36 | -51 | -62 |
12/17/13 16:06 | 12/16/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 301 | 200 | 4 | -24 | -21 | -4 | -2 | 4 | 0 | 7 | -8 | -20 | -46 | -68 |
12/17/13 16:06 | 12/16/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -133 | 66.34 | 33 | -2 | -100 | 0 | D | 301 | 200 | 4 | -24 | -21 | -4 | -2 | 4 | 0 | 7 | -8 | -20 | -46 | -68 |
12/4/13 17:01 | 12/2/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 39 | 13.01 | 33 | 3 | | 0 | D | 327 | 217 | -6 | -27 | -19 | -16 | 0 | -4 | -2 | -4 | 6 | -28 | -53 | -70 |
12/4/13 17:01 | 12/2/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -211 | 70.42 | 33 | -3 | -100 | 0 | D | 327 | 217 | -6 | -27 | -19 | -16 | 0 | -4 | -2 | -4 | 6 | -28 | -53 | -70 |
11/19/13 17:00 | 11/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 334 | 223 | 9 | -23 | -23 | -30 | -8 | -21 | -2 | 5 | -1 | -1 | -52 | -69 |
11/19/13 17:00 | 11/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -152 | 76.09 | 33 | -2 | -100 | 0 | D | 334 | 223 | 9 | -23 | -23 | -30 | -8 | -21 | -2 | 5 | -1 | -1 | -52 | -69 |
11/5/13 16:00 | 11/1/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 46 | 13.01 | 33 | 4 | | 0 | D | 541 | 282 | 94 | -9 | 0 | 6 | -7 | -2 | -9 | -1 | -16 | -29 | -58 | -74 |
11/5/13 16:00 | 11/1/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -291 | 83.28 | 33 | -4 | -100 | 0 | D | 541 | 282 | 94 | -9 | 0 | 6 | -7 | -2 | -9 | -1 | -16 | -29 | -58 | -74 |
10/16/13 17:04 | 10/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 466 | 464 | 102 | -2 | -16 | -7 | -19 | -6 | 2 | 1 | -2 | -31 | -51 | -67 |
10/16/13 17:04 | 10/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -161 | 80.33 | 33 | -2 | -100 | 0 | D | 466 | 464 | 102 | -2 | -16 | -7 | -19 | -6 | 2 | 1 | -2 | -31 | -51 | -67 |
10/8/13 17:15 | 10/7/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 46 | 13.01 | 33 | 4 | | 0 | D | 583 | 521 | 138 | 30 | 1 | 7 | 9 | -3 | -10 | -5 | -2 | -17 | -47 | -55 |
10/8/13 17:15 | 10/7/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -326 | 93.17 | 33 | -4 | -100 | 0 | D | 583 | 521 | 138 | 30 | 1 | 7 | 9 | -3 | -10 | -5 | -2 | -17 | -47 | -55 |
9/18/13 16:05 | 9/16/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 482 | 454 | 126 | 36 | -6 | 0 | -5 | -5 | 4 | -1 | -1 | -21 | -37 | -58 |
9/18/13 16:05 | 9/16/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -180 | 89.77 | 33 | -2 | -100 | 0 | D | 482 | 454 | 126 | 36 | -6 | 0 | -5 | -5 | 4 | -1 | -1 | -21 | -37 | -58 |
8/20/13 17:06 | 8/16/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 509 | 501 | 198 | 44 | 22 | 4 | -5 | -6 | 4 | 8 | -1 | -11 | -26 | -62 |
8/20/13 17:06 | 8/16/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -177 | 88.71 | 33 | -2 | -100 | 0 | D | 509 | 501 | 198 | 44 | 22 | 4 | -5 | -6 | 4 | 8 | -1 | -11 | -26 | -62 |
7/16/13 17:00 | 7/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 26 | 13.01 | 33 | 2 | | 0 | D | 419 | 441 | 189 | 103 | 9 | 36 | 16 | 12 | 4 | 1 | 23 | 6 | -20 | -62 |
7/16/13 17:00 | 7/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -158 | 78.77 | 33 | -2 | -100 | 0 | D | 419 | 441 | 189 | 103 | 9 | 36 | 16 | 12 | 4 | 1 | 23 | 6 | -20 | -62 |
6/19/13 16:00 | 6/17/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 78 | 13.01 | 33 | 6 | | 0 | D | 277 | 333 | 188 | 66 | 48 | -8 | -14 | -8 | -1 | -3 | 26 | 39 | 6 | -43 |
6/19/13 16:00 | 6/17/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -392 | 65.27 | 33 | -6 | -100 | 0 | D | 277 | 333 | 188 | 66 | 48 | -8 | -14 | -8 | -1 | -3 | 26 | 39 | 6 | -43 |
5/17/13 16:30 | 5/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 78 | 13.01 | 33 | 6 | | 0 | D | 182 | 347 | 193 | 114 | 60 | 64 | 44 | 34 | -2 | -1 | 1 | 42 | 33 | -48 |
5/17/13 16:30 | 5/15/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -284 | 47.32 | 33 | -6 | -100 | 0 | D | 182 | 347 | 193 | 114 | 60 | 64 | 44 | 34 | -2 | -1 | 1 | 42 | 33 | -48 |
4/24/13 14:23 | 4/22/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | M.d | 78 | 13.01 | 20 | 6 | | 0 | D | 149 | 243 | 112 | 47 | 10 | 6 | 2 | 2 | -5 | 3 | 43 | 88 | 103 | 8 |
4/24/13 14:23 | 4/22/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sumeray Mark | MA | O | Chief Me | S.d | -244 | 40.74 | 20 | -6 | -100 | 0 | D | 149 | 243 | 112 | 47 | 10 | 6 | 2 | 2 | -5 | 3 | 43 | 88 | 103 | 8 |